Page 11 - Protara Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Protara therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Protara Therapeutics Today - Breaking & Trending Today

Protara Therapeutics (NASDAQ:TARA) & Cardiol Therapeutics (NASDAQ:CRDL) Critical Review

Protara Therapeutics (NASDAQ:TARA – Get Rating) and Cardiol Therapeutics (NASDAQ:CRDL – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations and risk. Insider & Institutional Ownership 50.3% of Protara Therapeutics shares […] ....

New York , United States , David Elsley , Weldon Smith , Jacqueline Zummo , Jesse Shefferman , Cardiol Therapeutics Inc , Protara Therapeutics Inc , Protara Therapeutics , Get Rating , Cardiol Therapeutics , Cardiol Therapeutic , Given Protara Therapeutic , Anthony Bolton , Protara Therapeutics Daily , Nasdaq Tara , Stock Comparison , Stock Analysis ,

Protara Therapeutics: Q1 Earnings Snapshot

NEW YORK — NEW YORK — Protara Therapeutics, Inc. on Thursday reported a loss of $9 million in its first quarter.
The New York-based company said it had a loss of 80 cents per. | May 4, 2023 ....

Protara Therapeutics Inc , Zacks Investment Research , Automated Insights , Protara Therapeutics , Nc Stock Exchange , Press Release , Ents Tara Us74365u1079 ,

Cardiol Therapeutics (NASDAQ:CRDL) vs. Protara Therapeutics (NASDAQ:TARA) Financial Contrast

Protara Therapeutics (NASDAQ:TARA – Get Rating) and Cardiol Therapeutics (NASDAQ:CRDL – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations and institutional ownership. Analyst Ratings This is a summary of recent ratings […] ....

New York , United States , Jacqueline Zummo , Weldon Smith , David Elsley , Jesse Shefferman , Cardiol Therapeutics Inc , Protara Therapeutics Inc , Protara Therapeutics , Get Rating , Cardiol Therapeutics , Given Protara Therapeutic , Cardiol Therapeutic , Anthony Bolton , Protara Therapeutics Daily , Nasdaq Tara , Stock Comparison , Stock Analysis ,

Protara Therapeutics (TARA) Announces Positive Preliminary Data from ADVANCED-1 Phase 1a Trial of TARA-002

Protara Therapeutics (TARA) Announces Positive Preliminary Data from ADVANCED-1 Phase 1a Trial of TARA-002
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Jathin Bandari , Klinische Einheit , Carolina Urologic Research Center , Exchange Commission , Drug Administration , Company Contact , Protara Therapeutics Inc , Protara Therapeutics Inc Nasdaq , Clinical Development Plan , American Urological Association , Chugai Pharmaceutical Co Ltd , Wall Street , Neal Shore , Medical Director , Chief Medical Officer , Bacillus Calmette Gu , Rare Pediatric Disease Designation , Protara Therapeutics , Private Securities Litigation Reform Act , United States Securities , Justineo Malleyprotara Therapeutics ,

Protara Therapeutics (NASDAQ:TARA) Stock Price Down 13.1%

Protara Therapeutics, Inc. (NASDAQ:TARA – Get Rating) shares fell 13.1% during trading on Tuesday . The stock traded as low as $3.00 and last traded at $3.12. 127,924 shares changed hands during mid-day trading, an increase of 356% from the average session volume of 28,032 shares. The stock had previously closed at $3.59. Analysts Set […] ....

Protara Therapeutics Company Profile , Renaissance Technologies , Protara Therapeutics Inc , Virtu Financial , Privium Fund Management United Kingdom Ltd , Protara Therapeutics , Get Rating , Protara Therapeutics Daily , Nasdaq Tara ,